Delivery Order SPE2DB22D3004-SPE2DB25FQ84D
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) valued at $12,491.82 under a firm fixed price contract type. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, and the performance location is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Rotarix vaccine in oral syringe format (1.5mL) with a ceiling value of $8,304.72. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set to be completed by August 13, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $6,644.97 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 milliliter units). This firm fixed-price delivery order, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,067.22 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5mL) with a firm fixed price structure. The contract, which was competitively awarded with no set-aside designation, is scheduled for ultimate completion on April 25, 2025, one day after the award date of April 24, 2025. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $24,953.40 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe 1.5ml format. This firm fixed-price contract, with an ultimate completion date of September 2, 2025, was competitively awarded without set-aside designation. The performance location is the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order represents a single procurement action under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a $26,579.88 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price contract represents a small component of the vendor's extensive pharmaceutical supply operations supporting federal medical procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $2,214.99 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Rotarix vaccine oral syringes (1.5mL). This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) under a firm fixed-price contract valued at $11,462.30. The order, issued on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-competitive, non-set-aside delivery of pharmaceutical products to support federal medical supply requirements. Performance will take place at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a $31.3K firm fixed price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ml) with an ultimate completion date of September 3, 2025. This competitively awarded, non-set-aside contract reflects AmerisourceBergen's ongoing role as a critical pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order was performed at...
- The Defense Logistics Agency awarded a delivery order valued at $6,959.21 to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5ml) on September 16, 2025, with completion scheduled for September 17, 2025. This competitively awarded, firm fixed-price delivery order was placed under no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FQ84DDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 mL) under a firm fixed price contract valued at $11,884.18. The award, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location in the same municipality. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent contract enables the company to supply a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The IDC serves the Defense Health Agency, U.S. Coast Guard, and other federal government healthcare systems, positioning AmerisourceBergen Drug Corp as a critical vendor within the DLA's medical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.9k | 9/22/25 |